Revolutionizing treatment
decisions for coronary
artery disease.

Quick, non-invasive,
wire-free 3D FFR guidance.

Learn More

Introducing the Cathworks

FFRangio System
FFRangio system

Confident answers for coronary artery disease.

Transform routine angiograms into objective multi-vessel physiologic, and anatomic insights, giving you the information you need to optimize PCI treatment decisions.

Sorry, your browser does not support inline SVG.

Elevate your practice with the proven benefits of FFR.

FFRangio delivers highly accurate multi-vessel FFR results without the need for an invasive pressure wire or hyperemic stimulus, making important FFR benefits practical for more patients.

FAME study: FFR-guided PCI improves outcomes and saves cost compared to angiography-guided PCI.

  • 30%

    Reduction in stents per patient*

  • 28%

    Relative Reduction in 1-year clinical events*

  • 14%

    Reduction in costs at 1-year**

See How FFRangio Works

Physician Perspectives

CVIT 2021: Dr. Rahul P. Sharma, Interventional Cardiologist and Director of Structural Interventions at Stanford Medical Center, shares his experience with FFRangio, including important clinical evidence and the benefits of FFRangio for routine clinical practice.

Watch the dr. Sharma CVIT Presentation arrow_forward
play_arrow

FFRangio in Clinical Practice

Dr. Rahul P. Sharma

Stanford Healthcare

play_arrow

FFRangio Compared to FFR Clinical Data

Dr. William F. Fearon

Stanford University Medical Center, California

play_arrow

Applicability of FFRangio in Serial Lesions Diffuse Disease

Dr. Carlos Collet Bortone

the Cardiovascular Center OLV AALST, Belgium

play_arrow

FFRangio in Routine Clinical Practice US Experience

Dr. Rahul P. Sharma

Stanford University Medical Center, California

“FFRangio has the potential to eventually replace wire-based FFR measurement and substantially increase physiological coronary lesion assessment in the catheterization laboratory, thereby leading to improved patient outcomes”

View Clinical Studies arrow_forward

FAST-FFR Trial: Fearon WF, et al. Circ. September 2018. 10.1161/CIRCULATIONAHA.118.037350.

Events

Sept27

TCT 2019

San Francisco, CA

Room 203,
Level 2 Moscone South,
Moscone Center
Event Details View All Events arrow_forward

Find out more.

*Required

FDA CE PMDA

Regulatory Status

The CathWorks FFRangio System has received United States 510(k) clearance, Europe CE approval, Israel Amar approval, and Japan PMDA approval.

*Tonino et al. N Engl J Med. January 15, 2009; 360:213-224;
**Fearon et al. Circulation. 2010;122:2545-2550;

expand_lessBack to top of page

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions

Accept